Capital Impact Advisors’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,889
Closed -$960K 78
2024
Q1
$960K Hold
23,889
1.25% 28
2023
Q4
$608K Buy
+23,889
New +$608K 0.8% 63